💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Isis Pharmaceuticals, Inc. (ISIS)
« Back to company indexISIS Chatter Timeline
Stock Ticker for ISIS
Most Active Tweeters for ISIS
| User | Tweets |
|---|---|
| @Allstocknews | 4 |
| @FlashAlert_me | 2 |
| @StkOptionCoach_ | 1 |
| @thedogepark | 1 |
Recent Tweets for ISIS
 |
@StkOptionCoach_ RT @StockTradersHQ: HQ Alert: $ISIS is now up 100% since our system entry just four months ago. See chart. http://t.co/XwjGTJzdIL May 8th 2021, 5:05am |
 |
@Allstocknews $ISIS Ionis to host 2021 virtual annual meeting of stockholders From our Stock News Alerts App May 5th 2021, 8:05pm |
|
@Allstocknews $ISIS New Form 10-Q for Ionis Pharmaceuticals Inc From our Stock News Alerts App May 5th 2021, 7:05pm |
 |
@FlashAlert_me $ISIS [15s. delayed] filed form 10-Q on May 05, 14:58:30 https://t.co/fpoyuED654 May 5th 2021, 6:05pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on May 05, 11:16:02: Item2.02: Results of Operations & Financial Condition https://t.co/1yWiITftHC May 5th 2021, 3:05pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - First Quarter 2021 Earnings Webcast From our Stock News Alerts App May 5th 2021, 11:05am |
|
@Allstocknews $ISIS Ionis reports first quarter 2021 financial results and recent business achievements From our Stock News Alerts App May 5th 2021, 11:05am |
 |
@thedogepark YOLOing into $ISIS coin May 3rd 2021, 1:05pm |
 |
@arcamids @StockMKTNewz not as bad as $ISIS April 27th 2021, 7:04pm |
|
@Allstocknews $ISIS New Form DEF 14A for Ionis Pharmaceuticals Inc From our Stock News Alerts App April 23rd 2021, 10:04am |
|
@Allstocknews $ISIS New Form DEFA14A for Ionis Pharmaceuticals Inc From our Stock News Alerts App April 23rd 2021, 10:04am |
 |
@ExecPayOrg Ionis Pharmaceuticals CEO Brett Monia's 2020 pay jumps 68% to $11M https://t.co/x9gQ0Aj4tX $ISIS #execpay April 23rd 2021, 10:04am |
|
@Allstocknews $ISIS Ionis to hold first quarter 2021 financial results webcast From our Stock News Alerts App April 21st 2021, 11:04am |
|
@Allstocknews $ISIS Ionis initiates pivotal clinical study of novel antisense medicine to treat patients with Alexander dis From our Stock News Alerts App April 20th 2021, 11:04am |
 |
@guardabosquesai RT @baran_MR_: After growing heat of $ISIS and #Syria war, the Syrian govern man ask help from United States, but they delay it to six mont… April 17th 2021, 11:04am |
 |
@saucegod3000 @hopes_revenge $ISIS is the way to go imo, they're on track for a comeback in the next few years, i feel it April 15th 2021, 9:04pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - 20th Annual Needham Healthcare Conference From our Stock News Alerts App April 11th 2021, 11:04am |
|
@Allstocknews $ISIS Ionis prices private placement of convertible senior notes From our Stock News Alerts App April 8th 2021, 11:04am |
|
@Allstocknews $ISIS Ionis announces proposed private placement of convertible notes From our Stock News Alerts App April 6th 2021, 8:04pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on April 06, 07:00:55: Item2.05: Costs Associated with Exit or Disposal Activit… https://t.co/EaLB0zL6br April 6th 2021, 11:04am |
 |
@snowman_crypto @c_eid86 @KyleMacLeanX $ISIS coin. April 5th 2021, 1:04pm |
|
@Allstocknews $ISIS Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS From our Stock News Alerts App April 5th 2021, 11:04am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - 3rd Annual Stifel CNS Day From our Stock News Alerts App March 31st 2021, 11:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 8-K on March 29, 10:23:28: Item5.03: Amendments to Articles of Incorporation or Byl… https://t.co/ikqJuKLMhh March 29th 2021, 2:03pm |
|
@Allstocknews $ISIS Ionis reports positive topline Phase 2 study results of its novel antisense treatment for hereditary an From our Stock News Alerts App March 29th 2021, 11:03am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - J.P. Morgan 10th Annual Napa Valley Forum From our Stock News Alerts App March 28th 2021, 12:03pm |
 |
@lbblazej @srqstockpicker Ummm. Cuz it used to be $ISIS Or am I not remembering correctly. March 24th 2021, 4:03am |
 |
@supersingr1 $isis gets 3 Downgrades (but still a lot of upside potential) -Morgan Stanley maintains Underweight PT $43 -Needha… https://t.co/C01Aooayvh March 23rd 2021, 2:03pm |
|
@supersingr1 Ark bought over 46,000 shares of $isis today despite Roche discontinuing Phase 3 dosing due to poor results (maybe… https://t.co/qK1qGwuX86 March 23rd 2021, 12:03am |
|
@Allstocknews $ISIS Ionis' partner provides update on clinical studies evaluating tominersen (IONIS-HTT Rx) From our Stock News Alerts App March 22nd 2021, 9:03pm |
 |
@Harjit73056728 $ISIS connection of PFI https://t.co/Zl8BdDtEX3 March 20th 2021, 11:03am |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Oppenheimer 31st Annual Healthcare Conference From our Stock News Alerts App March 16th 2021, 11:03am |
|
@Allstocknews $ISIS New Form 4 for Ionis Pharmaceuticals Inc From our Stock News Alerts App March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Research Swayze Eric: Acquired 460 of Common Stock at price $44.54 on… https://t.co/5bUEbYBHWA March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP & General Counsel O'NEIL PATRICK R.: Acquired 197 of Common Stock at pr… https://t.co/dsstvXrpoS March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Finance & CFO HOUGEN ELIZABETH L: Acquired 116 of Common Stock at pric… https://t.co/1ghGrS7H4c March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: EVP, Chief Development Offc Geary Richard S: Acquired 414 of Common Stock a… https://t.co/YVUBwdj1dS March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Corp Dev and Cml Officer Cadoret-Manier Onaiza: Acquired 492 of Commo… https://t.co/Z3svTfXl6v March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Scientific Officer BENNETT C FRANK: Acquired 112 of Common Stock at p… https://t.co/s6IlvEvNce March 3rd 2021, 1:03am |
|
@FlashAlert_me $ISIS [15s. delayed] filed SEC form 4: Chief Executive Officer Monia Brett P: Disposed 236 of Common Stock at pric… https://t.co/98oVbWq2lu March 3rd 2021, 1:03am |
 |
@_ViralTaco @russian_market $ISIS March 2nd 2021, 11:03am |
|
@Allstocknews $ISIS Ionis establishes new grant program to advance research and understanding of transthyretin amyloidosis From our Stock News Alerts App March 1st 2021, 12:03pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - SVB Leerink 10th Annual Global Healthcare Conference From our Stock News Alerts App February 25th 2021, 12:02pm |
|
@Allstocknews $ISIS New Form 10-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 24th 2021, 9:02pm |
|
@FlashAlert_me $ISIS [15s. delayed] filed form 10-K on February 24, 15:34:10 https://t.co/k89NTJylNL February 24th 2021, 8:02pm |
|
@Allstocknews $ISIS New Form 8-K for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 24th 2021, 2:02pm |
|
@Allstocknews $ISIS Ionis reports fourth quarter and full year 2020 financial results and recent business achievements From our Stock News Alerts App February 24th 2021, 12:02pm |
|
@Allstocknews $ISIS Ionis Pharmaceuticals Inc - Fourth Quarter 2020 Earnings Webcast From our Stock News Alerts App February 23rd 2021, 12:02pm |
|
@Allstocknews $ISIS Ionis to present at upcoming investor conferences From our Stock News Alerts App February 19th 2021, 12:02pm |
|
@Allstocknews $ISIS New Form SC 13G for Ionis Pharmaceuticals Inc From our Stock News Alerts App February 16th 2021, 5:02pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
